Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
Press Releases
May 31, 2011
Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule
...
Read More
May 26, 2011
U.S. Government Issues Request for Proposal for the Supply of 44.75 Million Doses of BioThrax over Next 5 Years
...
Read More
May 25, 2011
Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference
...
Read More
May 17, 2011
Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 19, 2011 at 10:00 am Eastern; Webcast Will Be Available
...
Read More
May 5, 2011
Emergent BioSolutions Reports Financial Results for First Quarter 2011
...
Read More
May 2, 2011
U.S. Government Expands BioThrax Procurement Contract to 17.92M Doses from 14.5M Increasing Contract Value by up to $101 Million
...
Read More
April 28, 2011
Oxford-Emergent Tuberculosis Consortium Vaccinates Last Infant in Phase IIb Clinical Trial
...
Read More
April 14, 2011
Emergent BioSolutions to Release First Quarter 2011 Financial Results and Conduct a Conference Call on May 5, 2011
...
Read More
April 13, 2011
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Named Biotech CEO of the Year at the World Vaccine Congress
...
Read More
March 24, 2011
Emergent BioSolutions Observes World TB Day
...
Read More
March 22, 2011
Emergent BioSolutions to Present at Needham & Company Healthcare Conference
...
Read More
March 10, 2011
Emergent BioSolutions Reports Financial Results for Full Year 2010
...
Read More
1
2
…
42
43
44
…
58
59
